• Tidak ada hasil yang ditemukan

Nurse's Pocket Drug Guide 2008

N/A
N/A
Protected

Academic year: 2023

Membagikan "Nurse's Pocket Drug Guide 2008"

Copied!
386
0
0

Teks penuh

For more information, please contact George Hoare, Special Sales, at [email protected] or. Except as permitted under the Copyright Act 1976 and the right to store and retrieve one copy of the work, you may not decompile, disassemble, reverse engineer, reproduce, modify, create derivative works based on, transmit, distribute, distribute , sell, publish or sublicense the work or any part thereof without McGraw-Hill's prior permission. You may use the work for your own non-commercial and personal use; any other use of the work is strictly prohibited.

McGraw-Hill and its licensors do not warrant or guarantee that the features of the Work will meet your requirements or that its operation will be uninterrupted or error-free. Neither McGraw-Hill nor its licensors shall be liable to you or anyone else for any inaccuracy, error or omission, howsoever caused, in the Work or for any damages arising therefrom. McGraw-Hill has no responsibility for the content of any information accessed through the work.

In no event shall McGraw-Hill and/or its licensors be liable for any indirect, incidental, special, punitive, consequential or similar damages arising out of the use of or inability to use the work, even if any of them have been advised about the possibility of such damage. We hope that this book will help you learn some of the key elements of prescribing medication and enable you to care for your patients in the best way possible.

MEDICATION KEY

Adrenergic Blockers

Receptor Antagonists Candesartan (Atacand)

Ciprofloxacin Ophthalmic (Ciloxan) Erythromycin Ophthalmic (Iloticin Ophthalmic) Gentamicin Ophthalmic. Garamycin, Genoptic, Gentacidin, Gentak) Neomycin & Dexam-. Aluminum hydroxide with magnesium hydroxide and simethicone (Mylanta, Mylanta II, Maalox Plus) Aluminum hydroxide. Naphazoline and pheniramine acetate (Naphcon A) Nepafenac (Nevanac) Olopatadine (Patanol) Pemirolast (Alamast) Rimexolone (Vexol. Ophthalmic).

Pentazocine (Talwin) Propoxyphene (Darvon) Propoxyphene & Acetaminophen (Darvocet) Propoxyphene & Aspirin. Darvon compound- 65, Darvon-N with aspirin). Hydrocodone, Chlorpheniramine, Phenylephrine, Acetaminophen and Caffeine (Hycomin), Potassium Iodide (SSKI, . Thyro-Block) Pseudoephedrine.

GENERIC DRUG DATA

Protease Inhibitor (Prolastin) [Alpha Protease In- hibitor Replacement/Respiratory agent] Uses: * α 1 -Antitrypsin

1 gtt in eye(s) tid (wait 15 min to insert contacts) Caution: [B, ?] Contra: MAOI therapy Disp: 0.2% soln SE: Local irritation, HA, fatigue Interactions: ↑Antihypertensive effects, BB, cardiac glycosides, CNS depressants; ↓effects with/. Bleeding with anticoagulants; ↑nephrotoxicity with aminoglycosides, loop of Henle diuretics; ↑ effects with probenecid; ↓effects with antacids, chloramphenicol; ↓effects of oral contraceptives Laboratories:+ Direct Coombs test; ↑LFT, alkaline phosphatase,. Verapamil Labs Effects: Monitor lipids NIPE: Take with food and fluids Colestipol (Colestid) [antilipemic/bile acid sequestrant].

John's wort, alfalfa sprouts, astragalus, echinacea, licorice; ↓effects OF immunizations Labs:↑SCr, BUN, total bilirubin, K+, alkaline phosphatase, lipidsNIPE: Monitor for hyperglycemia, hyperkalemia, hyperuricemia, risk of photosensitivity - use sunscreen. 4 mg/kg q48h Caution:[B, ?] w/HMG-CoA inhibitors Disp:Inj 250, 500 mg/10 mLLSE:Constipation, N/V/D, HA, rash, site Rxn, muscle pain/weakness, edema , cellulitis, hypo/hyperglycemia, ↑alkaline phosphatase, cough, back pain, abdominal pain, ↓K+, anxiety, chest pain, sore throat, heart failure, confusion, Candida InfxnsNotes: Monitor CPK weekly; Consider D/C to stop HMG-CoA reductase inhibitors (↑myopathy risk) Interactions:↑effects OF anticoagulants; ↓effects OF tobramycin; ↓effects with tobramycin; Labs: Monitor CPK, LFTs, PT, INR;. CNS depressants, antihistamines, opioids, MAOIs, TCAs, EtOH; ↑effects OF metoprololLabs:↓Response to allergic skin test NIPE:↑Risk of photosensitivity - use sunscreen.

C (D if given short term), +] PO Anticoagulants, MRX, Hypoglycaemic Agents, Phenytoin, CyclosporineContra:Infants <2 months Disp:Susperythromycin Ethylsuccinate 200mg/Sulfisoxazole 600mg/5ml ml) SE:GI Disorder Additional interactions:↑ Effects of sulfonamides with ASA, diuretics, NSAIDs, probenecid Labs: False + urine protein NIPE: ↑ Risk of photosensitivity – use sunscreen. Nausea, bloating, breast enlargement/tenderness, edema, HA, hypertriglyceridemia, gallbladder Dz Interactions: ↑Effects OF Corticosteroids; ↓effects with. Effects OF ASA, Benzodiazepines, Metoprolol, TCAs NIPE: Check for changes in vision or ↓tolerance of contact lenses.

Ingredient Sensitivity Disp.: Tabs mg SE: Fatigue, Dizziness, HA, Pruritus, N/D Interactions: ↑Effects with Cimetidine, Probenecid, Theophylline; ↑ effects of digoxin NIPE: It is not affected by food, therapy is most effective if taken after 72 hours of rash. Risk of hypokalemia with amphotericin B, thiazide diuretics, loop of Henle diuretics; ↓effects with rifampin, barbiturates, hydantoins; ↓effects of ASA, INH Labs:↓Serum K+NIPE:Eval for fluid retention. Reversal sedative effects of benzodiazepines and general anesthesia* Action: benzodiazepine receptor antagonist Dose: Adults. 0.2 mg IV over 15 s; repeat PRN, up to 1 mg max (3 mg max in benzodiazepine OD).

Total T4 levels Interactions:↑Effects with anesthetics, EtOH, echinacea; ↑effects of anticoagulants, cyclosporine, insulin, hypoglycemia, tacrolimus; ↓effects w/. Interferon β-1b (Betaseron) [Immunomodulator] Use: *MS, relapsing-remitting and secondary progressive* Action: Biological response modifier Dose:0.25 mg SQ qd Warning:[C, ?] Contra:Allergy to human albumin products Disp: Powder for injection 0.3 mg SE: Flu-like syndrome, depression, blood dyscrasias; Interactions:↑Effects OF theophylline, zidovudine Labs:↑LFTs, BUN, urine protein NIPE:↑Risk of photosensitivity—use sunscreen, abortion;. Effects OF myelosuppressants, theophylline, zidovudine NIPE:↑Fluids up to 2–3 L/d,NEtOH, CNS depressants; activated charcoal more effective.

Fatigue,↓BPinteractions:↑Risk OF hyperkalemia with K-sparing diuretics, trimethoprim, K supls; ↑effects FROM Li Labs:↑BUN, SCr; ↓HmgNIPE:NPRG, breastfeeding. Effects with α-blockers, diuretics ↑risk OF hyperkalemia with K-sparing diuretics, trimethoprim, salt substitutes; ↑risk OF cough with capsaicin; ↑effects of insulin,. Allergy to other quinolones, children < 18 y Disp:Tabs 400 mg SE:Photosensitivity, Szs, HA, dizziness Interactions:↑Effects with cimetidine, probenecid; ↑effects of cyclosporine, warfarin, caffeine; ↓effects with antacids Labs:↑LFTs,↓K+ NIPE:↑Risk of photosensitivity—use sunscreen, ↑fluids up to 2 L/d.

Disp: Caps 200, 400 mg; susp 100, 200 mg/5 mL SE:D Interactions:↑Effects with probenecid; ↑effects OF warfarin; ↑ nephrotoxicity w/ aminoglycosides, furosemide NIPE: Take without food.

Referensi

Dokumen terkait

5, 2014 ラン藻の代謝改変によるバイオプラスチック増産 ラン藻代謝工学の新展開 ラン藻は,酸素発生型の光合成を行う細菌である(図 1).淡水,海水,土壌から深海や温泉に至るまで,あら ゆる環境に生育していることが知られている.光合成を 行うことで,光エネルギーと大気中の二酸化炭素の利用 が可能であることから,ラン藻を用いたバイオエネル